#63: The Machine: Depomed to Present at the BIO CEO & Investor Conference
Depomed, Inc. (NASDAQ:DEPO) today announced that president and chief... |
February 5, 2008
08:57:51 AM |
#62: The Machine: Depomed Receives FDA Approval for 1000 mg Strength Tablets of Glumetza
Depomed, Inc. (NASDAQ:DEPO) announced today that it has received
... |
January 29, 2008
02:21:33 AM |
#61: NewsBot: Depomed Receives FDA Approval for 1000 mg Strength Tablets of Glumetza
Depomed, Inc. (NASDAQ:DEPO) announced today that it has received
approval... |
January 16, 2008
09:31:34 AM |
#60: NewsBot: DEPO News Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) announced today... |
April 2, 2007
07:00:00 AM |
#59: NewsBot: DEPO News Depomed Appoints David Zenoff to Board of Directors
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) announced today... |
March 23, 2007
04:00:00 AM |
#58: NewsBot: DEPO News Depomed Reports 2006 Year End Financial Results
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced... |
March 14, 2007
01:00:00 PM |
#57: NewsBot: DEPO News Depomed Files Investigational New Drug Application for Gabapentin GR for the Treatment of Postmenopausal Hot Flashes
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) announced today... |
March 12, 2007
04:00:00 AM |
#56: NewsBot: DEPO News Depomed Completes Patient Enrollment in Phase 3 Clinical Trial of Gabapentin GR in Postherpetic Neuralgia
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced... |
March 8, 2007
04:00:00 AM |
#55: NewsBot: DEPO News Depomed to Announce Fourth Quarter and Year End 2006 Financial Results on Wednesday, March 14
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced... |
February 28, 2007
04:00:00 AM |
#54: NewsBot: DEPO News Depomed to Present at the Oppenheimer Pain Management Conference
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced... |
February 27, 2007
04:00:00 AM |
#53: NewsBot: DEPO News Depomed Receives $10 Million License Fee from Esprit and Withdraws Arbitration Proceeding
MENLO PARK, Calif. & EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Depomed, Inc.... |
December 21, 2006
02:00:00 PM |
#52: NewsBot: DEPO News Depomed Announces Sweeping Interim Victory in Litigation against Ivax
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced a... |
December 20, 2006
01:04:00 PM |
#51: NewsBot: DEPO News Depomed Delivers Notice of Breach and Demand for Arbitration to Esprit Pharma
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced... |
December 18, 2006
05:00:00 AM |
#50: NewsBot: DEPO News Depomed Announces Equity Financing Commitment of Up to $30 Million
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced... |
December 12, 2006
05:00:00 AM |
#49: NewsBot: DEPO News Depomed Announces Strong Positive Phase II Trial Results for Once Daily Gabapentin GR(TM) to Treat Symptoms of Diabetic Peripheral Neuropathy
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (Nasdaq:DEPO) today announced... |
December 12, 2006
04:30:00 AM |
| 
| 
| 
| 
| 
| 
